I'm LongbridgeAI, I can summarize articles.Biotechnology company BioNTech (BNTX.US) fell over 6% in early trading, reporting at $104.7. According to sources, Pfizer is seeking to sell its remaining stake in its COVID-19 vaccine partner BioNTech. This equity sale is expected to bring Pfizer up to approximately $508 million in revenue. BioNTech stated that its collaboration with Pfizer remains unchanged and will not comment on any capital market activities of Pfizer
Biotechnology company BioNTech (BNTX.US) fell over 6% in early trading, reporting $104.7. According to insiders, Pfizer is seeking to sell its remaining stake in its COVID-19 vaccine partner BioNTech. This equity sale is expected to bring Pfizer up to approximately $508 million in revenue. BioNTech stated that its collaboration with Pfizer remains unchanged and will not comment on any capital market activities of Pfizer